H. Shahrabadi, A. Haghighi, R. Askari, Majid Asadi-Shekaari, Ahad Shafiei, Alfredo Caturano, Vincenzo Russo, G. Caminiti, Rosario Barone, M. Volterrani, A. Parisi, Ferdinando Iellamo, Pasquale Farsetti, Roberto Bei, M. Perrone
tlooto Summary
It is suggested that HIIT does not reverse METH-induced upregulation of cardiac fibrosis markers, and further studies are warranted to explore alternative or complementary interventions in the context of METH-associated cardiac fibrosis.
Abstract
BACKGROUND Methamphetamine (METH) use is associated with significant cardiac damage, including the development of cardiac fibrosis. While high-intensity interval training (HIIT) has demonstrated cardio-protective effects in various cardiovascular conditions, its potential role in mitigating METH-induced cardiac fibrosis remains unclear. This study aimed to investigate the effects of HIIT on the mRNA expression of cardiac fibrosis biomarkers in METH-dependent rats.
METHODS In this experimental study, the expression of collagen 1a1 (COL1A1), collagen 3a1 (COL3A1), periostin (POSTN), and alpha smooth muscle actin (α-SMA) genes was measured using real-time PCR across four groups: Sham, METH, METH-control (METH-CON), and METH-HIIT. Rats in the METH-HIIT group underwent an 8-week HIIT protocol during the withdrawal period following METH administration.
RESULTS Twenty-one days of METH administration significantly increased the mRNA expression of all measured fibrosis-related (P<0.05). However, the subsequent HIIT intervention did not significantly attenuate the elevated mRNA expression of these markers (P>0.05).
CONCLUSIONS These findings suggest that HIIT does not reverse METH-induced upregulation of cardiac fibrosis markers. Further studies are warranted to explore alternative or complementary interventions in the context of METH-associated cardiac fibrosis.
Citation format
SHAHRABADI, H., et al. The effects of high-intensity interval training on cardiac fibrosis biomarkers in rats with methamphetamine-induced cardiac fibrosis. JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS, 2026, 66(4): 574–581.